Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC17A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GNPDA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SKIV2L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREB3L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507387 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBE2F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRTAP17-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRD5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HN1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM168 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEDD4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on